ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Carlsmed aprevo® Wins Spine Technology Award

Carlsmed announced today that aprevo® has been recognized by Orthopedics This Week with the prestigious Spine Technology Award. This award was presented at a ceremony today at the North American Spine Society (NASS) meeting in Boston. The award is given annually to exemplary and innovative spine surgery products that improve spine care, as judged by a panel that includes leading spine surgeons. Early clinical data supporting aprevo® is being presented at NASS during the Innovative Technologies Session.

“The Carlsmed team is honored to accept this award from Orthopedics This Week for our breakthrough aprevo® technology,” said Mike Cordonnier, CEO of Carlsmed. “Our mission is to provide broad access to this technology for patients suffering from debilitating spinal disorders.”

The aprevo® patient-specific interbody fusion devices are made possible by Carlsmed’s proprietary Data to Device™ digital technologies. For each aprevo® patient, a personalized surgical plan is developed preoperatively and presented to the surgeon to achieve the optimal spinal alignment target. Upon approval of the plan, unique interbody devices are created for the patient to address their specific pathology.

"By intentionally creating implants to fit a patient's own bone, we can start to realize the potential of personalized medicine and its benefits to each individual patient,” says Vijay Yanamadala, M.D., neurosurgeon and Director of Spinal Deformity Surgery at Hartford HealthCare. “My goal is for the aprevo® surgery to be the last spine surgery that a patient will ever need.”

The aprevo® patient specific interbody fusion devices are currently 510(k) cleared by the FDA for commercial use in the US for anterior, lateral and transforaminal surgical approaches.

About Carlsmed

Carlsmed’s mission is to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. The company’s aprevo® devices are designed to improve the standard of care for the surgical treatment of adult patients with spinal malalignment. Carlsmed uses patient data and proprietary digital technologies to create optimal surgical plans and personalized aprevo® spine fusion devices to align with the surgeon’s goals for each patient.

For more information, visit carlsmed.com or contact us at info@carlsmed.com.

Contacts

Jodi Coe

760-521-0167

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+1.37 (0.56%)
AAPL  268.47
-1.30 (-0.48%)
AMD  233.54
-4.16 (-1.75%)
BAC  53.20
-0.09 (-0.17%)
GOOG  279.70
-5.64 (-1.98%)
META  621.71
+2.77 (0.45%)
MSFT  496.82
-0.28 (-0.06%)
NVDA  188.15
+0.07 (0.04%)
ORCL  239.26
-4.54 (-1.86%)
TSLA  429.52
-16.39 (-3.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.